Search Results
Search results for "OMass Therapeutics"
Results found for "OMass Therapeutics"
- Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
kinetic studies "G protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic
- Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
PTH-related protein (PTHrP) ligands and analogues for their pharmacologic activities and potential therapeutic
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- đź“° GPCR Weekly News, June 10 to 16, 2024
synaptic depression in dorsolateral striatum of adult male mice Methods & Updates in GPCR Research RNA therapeutics
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
accurately reflect native biological processes and preclinical research can more reliably translate into therapeutic Trends in clinical success rates and therapeutic focus. The mass action equation in pharmacology. Br J Clin Pharmacol. 2016;81(1):41-51. 32.        Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Our results suggest that strategies to selectively target OGR1 expression may represent a novel therapeutic
- Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
2022 "The glucagon-like peptide-1 receptor (GLP-1R) plays a key role in metabolism and is an important therapeutic
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
week: Â nanomedicines targeting PAR2 for sustained analgesia; Emerging Voices in GPCR Biology; Domain Therapeutics
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
discrete and separable effects and provide proof of concept for the development of safer GPCR-targeting therapeutics
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
regulating the PI3K/AKT/GSK-3β and MEK/ERK pathways in amygdalae of male mice, implicating a potential, therapeutic
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), is receiving renewed attention for their potential therapeutic
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the...
Our results suggest that GPR15/GPR15L have a pathogenic role in RA and their antagonizing could be a therapeutic
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Pc(4-4) may become a promising candidate for future therapeutic cancer treatment."
- Pharmacologic Models
How the Mass Action Law underpins nearly every model Future of Receptor Theory: Linkage vs.
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
study biased signaling pathways, improving our understanding of GPCR functional diversity and their therapeutic
- Precise druggability of the PTH type 1 receptor
PTHR signaling that could be extended to GPCRs to expedite discoveries of small molecules as novel therapeutic
- Fluorescence Polarization in GPCR Research
compounds that interact with molecular targets involved in disease pathways is where the development of new therapeutics
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
and stabilizing IGF1R, and suggests that it may serve as a valuable prognostic factor and potential therapeutic
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
particularly aggressive and heterogeneous disease with few effective targeted therapies and precision therapeutic
- Do You Believe AI Could Accelerate Drug Discovery?
challenges is crucial to fully harness AI's potential in accelerating drug discovery and optimizing therapeutic
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Leverage this model to stay ahead of therapeutic complexity.
- G protein-coupled receptors that influence lifespan of human and animal models
substantial participation in a wide variety of processes of human pathophysiology and are one of the main therapeutic
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Endocrine Metabolic GPCRs 2026 and Biophysical Society Meeting previews; positive ACCESS data for Structure Therapeutics
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
puzzles and underscores the importance of understanding cellular processes at the molecular level for therapeutic
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics
- TLR4 biased small molecule modulators
Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
the current status of ligand development targeting LPA receptors to modulate LPA signaling and their therapeutic
- Your GPCR Program Decisions Depend on Good Data Interpretation
drug discovery; new strategies for inflammatory disease treatment; growth strategies from Tectonic Therapeutics












